Elite Pharmaceuticals (ELTP) EV to EBITDA (2010 - 2026)
Elite Pharmaceuticals' EV to EBITDA came in at 5.85 for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 61.2% from 15.07 a year earlier and down 40.6% from the prior quarter.
Elite Pharmaceuticals (ELTP) EV to EBITDA (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Elite Pharmaceuticals reported EV to EBITDA of 3.46, down 75.5% year-over-year; for FY2026 (ended Mar 31, 2026), it was 7.06, down 67.2% from FY2025.
- Going back by fiscal year, EV to EBITDA was 21.53 in FY2025 (+71.4%), 12.56 in FY2024 (+180.7%), 4.48 in FY2023 (+28.9%) and 3.47 in FY2022 (-79.3%).
- The fiscal Q2 2027 figure represents the lowest quarterly EV to EBITDA since fiscal Q1 2024.
- Year-over-year, EV to EBITDA has declined for five consecutive quarters, with an average decline of 5.3% over the last eight quarters.
- The fastest year-over-year change in EV to EBITDA over five years came in fiscal Q3 2024 (growth of 736.2%), and the weakest in fiscal Q4 2022 (a decline of 79.3%).
- Business Quant data shows ELTP's EV to EBITDA at 9.85 (Q1 2027), 7.06 (Q4 2026) and 9.77 (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,291.18 Bn | 1,264.79 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 686.56 Bn | 606.42 Bn | 17.30 Bn |
| 3 | AbbVie | 525.29 Bn | 493.30 Bn | 13.12 Bn |
| 4 | Merck | 362.24 Bn | 325.18 Bn | 13.19 Bn |
| 5 | Novartis Ag | 313.66 Bn | 286.90 Bn | - |
| 6 | Astrazeneca | 286.68 Bn | 260.20 Bn | 13.26 Bn |
| 7 | Amgen | 253.44 Bn | 205.10 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 210.62 Bn | 185.73 Bn | 6.73 Bn |
| 9 | Pfizer | 165.41 Bn | 112.77 Bn | 12.56 Bn |
| 10 | Elite Pharmaceuticals | 397.46 Mn | 270.87 Mn | 15.99 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.85 |
| Jun 30, 2026 | 9.85 |
| Mar 31, 2026 | 7.06 |
| Dec 31, 2025 | 9.77 |
| Sep 30, 2025 | 15.07 |
| Jun 30, 2025 | 19.42 |
| Mar 31, 2025 | 21.60 |
| Dec 31, 2024 | 41.32 |
| Sep 30, 2024 | 25.28 |
| Jun 30, 2024 | 14.12 |
| Mar 31, 2024 | 12.57 |
| Dec 31, 2023 | 17.01 |
| Sep 30, 2023 | 12.81 |
| Jun 30, 2023 | 5.58 |
| Mar 31, 2023 | 4.48 |
| Dec 31, 2022 | 2.03 |
| Sep 30, 2022 | 3.67 |
| Jun 30, 2022 | 4.87 |
| Mar 31, 2022 | 3.47 |
| Dec 31, 2021 | 5.26 |
Elite Pharmaceuticals EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();